title: Cytotoxic T lymphocytes: the future of cancer stem cell eradication?
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Saijo
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Hirohashi
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Torigoe
authors.forename: Vitaly
authors.initials: V
authors.lastname: Kochin
authors.forename: Hiroki
authors.initials: H
authors.lastname: Takahashi
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Sato
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D009369:Neoplasms / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000637:transplantation
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines